Dividend30 May 2026, 04:00 pm
Titan Biotech Recommends ₹0.50 Dividend Per Share
AI Summary
The Board of Directors of Titan Biotech Ltd has recommended a dividend of ₹0.50 per equity share, subject to shareholder approval at the upcoming Annual General Meeting. The dividend, if declared, will be credited/dispatched to eligible shareholders as per the Companies Act, 2013. The board also approved the audited financial results for the year ended March 31, 2026, and the re-appointment of M/s Sanjay Kumar Garg & Associates as Cost Auditor, subject to shareholder ratification.
Key Highlights
- Titan Biotech recommends a dividend of ₹0.50 per equity share.
- Dividend is subject to shareholder approval at the AGM.
- Audited financial results for FY26 were approved.
- Re-appointment of Cost Auditor M/s Sanjay Kumar Garg & Associates approved.
- Pankaj Kumar Gupta appointed as Scrutinizer for the 34th AGM.
Price Impact
More from TITANBIO